| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-05 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |